Review article: Oesophageal disorders in chronic liver disease

Simple item page
dc.catalogadorgrr
dc.contributor.authorIdalsoaga Ferrer, Francisco Javier
dc.contributor.authorDiaz Piga, Luis Antonio
dc.contributor.authorAyares Campos, Gustavo Ignacio
dc.contributor.authorCabrera, Daniel
dc.contributor.authorChahuan Abde, Javier Nicolas
dc.contributor.authorMonrroy Bravo, Hugo Alfonso
dc.contributor.authorHalawi, Houssam
dc.contributor.authorArrese Jimenez, Marco Antonio
dc.contributor.authorArab Verdugo, Juan Pablo
dc.date.accessioned2024-08-21T20:51:15Z
dc.date.available2024-08-21T20:51:15Z
dc.date.issued2024
dc.description.abstractBackground: Oesophageal disorders and chronic liver disease are common worldwide and significantly impact quality of life. The intricate link between these conditions, including how oesophageal disorders like GERD, Barrett's oesophagus and oesophageal cancer affect and are affected by chronic liver disease, remains poorly understood. Aims: To review the relationship between oesophageal disorders and chronic liver disease, evaluating epidemiology, pathophysiology and therapeutic factors. Methods: We reviewed the literature on the relationship between oesophageal disorders and chronic liver disease, including cirrhosis, using the PubMed database Results: Oesophageal disorders such as gastroesophageal reflux disease, Barrett's oesophagus, oesophageal cancer, oesophageal motor disorders and oesophageal candidiasis are prevalent among individuals with cirrhosis, exacerbating the burden of liver disease. These diseases have a multifaceted symptomatology and pathogenic basis, posing a significant challenge in cirrhotic patients that necessitates careful diagnosis and management. Additionally, therapies frequently used for these diseases, such as proton pump inhibitors, require careful consideration in cirrhotic patients due to potential adverse effects and altered pharmacokinetics. Managing oesophageal disorders in cirrhotic patients requires a cautious approach due to possible interactions with medications and the risk of adverse effects. Furthermore, symptoms associated with these conditions are often exacerbated by common interventions in patients with cirrhosis, such as band ligation for oesophageal varices. Conclusions: Oesophageal disorders are common in cirrhosis and increase the disease burden. These conditions require careful management due to complex symptoms and treatment risks. Proton pump inhibitors and other therapies must be used cautiously, as cirrhosis interventions can worsen symptoms.
dc.description.funderFondo Nacional de Desarrollo Cientifico y Tecnologico
dc.fechaingreso.objetodigital2024-08-21
dc.fuente.origenWOS
dc.identifier.doi10.1111/apt.18193
dc.identifier.eissn1365-2036
dc.identifier.issn0269-2813
dc.identifier.scopusidSCOPUS_ID:2-s2.0-85200057293
dc.identifier.urihttps://doi.org/10.1111/apt.18193
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/87588
dc.identifier.wosidWOS:001280981700001
dc.information.autorucEscuela de Medicina; Idalsoaga Ferrer, Francisco Javier; 0000-0001-5607-0698; 1017394
dc.information.autorucEscuela de Medicina; Diaz Piga, Luis Antonio; 0000-0002-8540-4930; 179253
dc.information.autorucEscuela de Medicina; Ayares Campos, Gustavo Ignacio; 0000-0002-8651-2255; 1033904
dc.information.autorucEscuela de Medicina; Chahuan Abde, Javier Nicolas; 0000-0003-1261-6200; 187210
dc.information.autorucEscuela de Medicina; Monrroy Bravo, Hugo Alfonso; 0000-0002-4740-3945 ; 182401
dc.information.autorucEscuela de Medicina; Arrese Jimenez, Marco Antonio; 0000-0002-0499-4191; 76095
dc.information.autorucEscuela de Medicina; Arab Verdugo, Juan Pablo; 0000-0002-8561-396X; 132745
dc.language.isoen
dc.nota.accesocontenido completo
dc.publisherWILEY
dc.revistaAlimentary Pharmacology & Therapeutics
dc.rightsacceso abierto
dc.rights.licenseCC BY-NC 4.0 Attribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titleReview article: Oesophageal disorders in chronic liver disease
dc.typeartículo de revisión
sipa.codpersvinculados1017394
sipa.codpersvinculados179253
sipa.codpersvinculados1033904
sipa.codpersvinculados187210
sipa.codpersvinculados182401
sipa.codpersvinculados76095
sipa.codpersvinculados132745
sipa.trazabilidadWOS;2024-08-17
sipa.trazabilidadORCID;2024-08-19
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Aliment Pharmacol Ther - 2024 - Idalsoaga - Review article Oesophageal disorders in chronic liver disease.pdf
Size:
3.37 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas